Edoardo Garbo

9PUBLICATIONS
127CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 27, 2026
Cancer Vaccine Strategies in Non-Small Cell Lung Cancer.

|Jun 22, 2026
EML4-ALK mediates resistance to KRAS G12C inhibition and induces an oncogenic dependency by rewiring signaling through the wild-type RAS pathway.

|May 18, 2026
Clinical outcomes and predictors of response to PD-(L)1 blockade in patients with NSCLC without actionable genomic alterations who never used tobacco.

|Sep 09, 2025
Real-world outcomes of neoadjuvant chemoimmunotherapy in patients with nonsmall cell lung cancer: Predictors of surgery, pathologic complete response, and event-free survival.

Alissa J Cooper, Edoardo Garbo, Andrea Arfe

|Aug 27, 2025
First-Line MET Tyrosine Kinase Inhibitors versus Immunotherapy ± Chemotherapy for Patients with MET Exon 14 Skipping Mutant Metastatic NSCLC.

Federica Pecci, Hui Li, Alessandro Di Federico

|Jun 11, 2025
Efficacy and Safety of Tarlatamab in a Patient With Advanced Delta-Like Ligand 3-Positive Large Cell Neuroendocrine Lung Carcinoma and Untreated Brain Metastases: A Case Report.

Eleonora Gariazzo, Sanna Laaksonen, Stephanie Canty

Pageof 2

Frequent Collaborators

5 joint publications

Biagio Ricciuti

4 joint publications

Mihaela Aldea

4 joint publications

Mark M Awad

3 joint publications

Valentina Santo